Page 61 - Livre électronique des RFTP 2024
P. 61
CONCLUSION:
Our study represents the first worldwide investigation of 15-Epi Lipoxin A4 as a
biomarker for inflammation resolution and severity in COPD, aiming to deepen
understanding of the etiopathogenic processes involved in this chronic condition
.
59 | P age
